{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:48:28Z","timestamp":1791967708625,"version":"4.3.4"},"reference-count":59,"publisher":"F1000 Research Ltd","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["openresearchafrica.org"],"crossmark-restriction":false},"short-container-title":["Open Res Africa"],"abstract":"<ns5:p>\n                    Background Placental malaria (PM) remains a leading driver of maternal and neonatal mortality, largely attributed to the sequestration of\n                    <ns5:italic>Plasmodium falciparum<\/ns5:italic>\n                    \u2013infected red blood cells in the placenta. For decades, PM vaccine development has singularly focused on VAR2CSA, the immunodominant variant surface antigen. However, extreme polymorphism, limited cross-strain protection, and the structural complexity of VAR2CSA have hindered the development of a highly efficacious PM vaccine, necessitating a paradigm shift. Methods This review examines existing literature to map potential vaccine antigens implicated in placental malaria ,and outlines a comprehensive vaccine development pipeline. It synthesizes emerging data on antigen expression profiles, immunogenicity, and mechanistic roles in placental pathogenesis. In addition, it highlights both key placental and blood-stage antigens expressed during pregnancy and reviews identification and testing strategies to guide rational PM vaccine design. Results This Review maps the expanding antigenic landscape of PM beyond VAR2CSA, identifying non-canonical surface and exported proteins, including SURFINs, PHISTs, PfRON3, and\n                    <ns5:italic>Pf<\/ns5:italic>\n                    CSA-L, as critical targets that may circumvent current bottlenecks. The findings highlight the relevance of these antigens in placental malaria pathogenesis and their potential as alternative or complementary vaccine candidates. Conclusions Furthermore, we propose an integrated framework for rational vaccine design that couples high-throughput antigen discovery and structural immunogen engineering with multivalent formulation strategies. By bridging the gap between molecular parasitology and translational immunology, this roadmap offers a strategic path toward a broadly protective placental malaria (PM) vaccine.\n                  <\/ns5:p>","DOI":"10.12688\/openresafrica.16523.1","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:04:07Z","timestamp":1777547047000},"page":"18","update-policy":"https:\/\/doi.org\/10.12688\/openresafrica.crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Beyond VAR2CSA: redefining the antigenic landscape of placental malaria vaccines"],"prefix":"10.12688","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4983-5733","authenticated-orcid":false,"given":"Lucy","family":"Mwai","sequence":"first","affiliation":[{"name":"1Centre for Malaria Elimination, Institute of Tropical Medicine Thika Mount Kenya University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purity","family":"Gacheri Limbua","sequence":"additional","affiliation":[{"name":"Thika Mount Kenya University School of Pure and Applied Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7516-522X","authenticated-orcid":false,"given":"Jesse","family":"Gitaka","sequence":"additional","affiliation":[{"name":"1Centre for Malaria Elimination, Institute of Tropical Medicine Thika Mount Kenya University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2772-7579","authenticated-orcid":false,"given":"Bernard","family":"N. Kanoi","sequence":"additional","affiliation":[{"name":"1Centre for Malaria Elimination, Institute of Tropical Medicine Thika Mount Kenya University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2560","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"e10390","DOI":"10.1016\/J.HELIYON.2022.E10390","article-title":"Targeting the Plasmodium falciparum proteome and organelles for potential antimalarial drug candidates.","volume":"8","author":"J Abugri","year":"2022","journal-title":"Heliyon."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e1001685","DOI":"10.1371\/JOURNAL.PMED.1001685","article-title":"Efficacy and Safety of the RTS,S\/AS01 Malaria Vaccine during 18 Months after Vaccination: A Phase 3 Randomized, Controlled Trial in Children and Young Infants at 11 African Sites.","volume":"11","author":"S Agnandji","year":"2014","journal-title":"PLoS Med."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1-13","DOI":"10.1186\/S12936-025-05299-5\/FIGURES\/4","article-title":"Safety, tolerability and immunogenicity of a condensed, multi-dose prime regimen of PfSPZ Vaccine for the prevention of Plasmodium falciparum malaria infection.","volume":"24","author":"A Berry","year":"2025","journal-title":"Malar. J."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1186\/S12936-016-1527-8","article-title":"Clinical development of placental malaria vaccines and immunoassays harmonization: a workshop report.","volume":"15","author":"A Ch\u00eane","year":"2016","journal-title":"Malar. J."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1-21","DOI":"10.1186\/s12916-019-1467-6","article-title":"Pregnancy-specific malarial immunity and risk of malaria in pregnancy and adverse birth outcomes: a systematic review.","volume":"18","author":"J Cutts","year":"2020","journal-title":"BMC Med."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1809-1818","DOI":"10.1016\/S0140-6736(21)00943-0","article-title":"Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.","volume":"397","author":"M Datoo","year":"2021","journal-title":"Lancet."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1366-1382","DOI":"10.1016\/S1473-3099(24)00360-8","article-title":"Safety and efficacy of PfSPZ Vaccine against malaria in healthy adults and women anticipating pregnancy in Mali: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials.","volume":"24","author":"H Diawara","year":"2024","journal-title":"Lancet Infect. Dis."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"315-323","DOI":"10.1038\/s41684-023-01274-2","article-title":"Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA.","volume":"52","author":"J Doritchamou","year":"2023a","journal-title":"Lab Anim."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e1011370","DOI":"10.1371\/JOURNAL.PPAT.1011370","article-title":"A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us?.","volume":"19","author":"J Doritchamou","year":"2023b","journal-title":"PLoS Pathog."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"215-226","DOI":"10.1080\/14760584.2021.1878029","article-title":"Progress and new horizons toward a VAR2CSA-based placental malaria vaccine.","volume":"20","author":"J Doritchamou","year":"2021","journal-title":"Expert Rev. Vaccines."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/NCOMMS1615","article-title":"The Blood-Stage Malaria Antigen PfRH5 is Susceptible to Vaccine-Inducible Cross-Strain Neutralizing Antibody.","volume":"2","author":"A Douglas","year":"2011","journal-title":"Nat. Commun."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"4875-4883","DOI":"10.1128\/IAI.01978-05\/SUPPL_FILE\/SUPPLFIG1.DOC","article-title":"Transcribed var genes associated with placental malaria in Malawian women.","volume":"74","author":"M Duffy","year":"2006","journal-title":"Infect. Immun."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1-12","DOI":"10.1186\/S12936-016-1296-4\/FIGURES\/3","article-title":"Differences in PfEMP1s recognized by antibodies from patients with uncomplicated or severe malaria.","volume":"15","author":"M Duffy","year":"2016","journal-title":"Malar. J."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1-9","DOI":"10.1038\/s41541-020-0196-3","article-title":"Malaria vaccines since 2000: progress, priorities, products.","volume":"5","author":"P Duffy","year":"2020","journal-title":"NPJ Vaccines."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1371-1381","DOI":"10.1111\/J.1462-5822.2006.00760.X","article-title":"Variant antigen gene expression in malaria.","volume":"8","author":"R Dzikowski","year":"2006","journal-title":"Cell. Microbiol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e1000569","DOI":"10.1371\/JOURNAL.PPAT.1000569","article-title":"Plasmodium falciparum Heterochromatin Protein 1 Marks Genomic Loci Linked to Phenotypic Variation of Exported Virulence Factors.","volume":"5","author":"C Flueck","year":"2009","journal-title":"PLoS Pathog."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"7483-7488","DOI":"10.1016\/J.VACCINE.2015.10.011","article-title":"Designing a VAR2CSA-based vaccine to prevent placental malaria.","volume":"33","author":"M Fried","year":"2015","journal-title":"Vaccine."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"634508","DOI":"10.3389\/FIMMU.2021.634508\/BIBTEX","article-title":"Progress and Insights Toward an Effective Placental Malaria Vaccine.","volume":"12","author":"B Gamain","year":"2021","journal-title":"Front. Immunol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1-10","DOI":"10.1038\/s41598-019-53334-8","article-title":"VAR2CSA binding phenotype has ancient origin and arose before Plasmodium falciparum crossed to humans: implications in placental malaria vaccine design.","volume":"9","author":"S Gangnard","year":"2019","journal-title":"Sci. Rep."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"498-511","DOI":"10.1038\/nature01097","article-title":"Genome sequence of the human malaria parasite Plasmodium falciparum.","volume":"419","author":"M Gardner","year":"2002","journal-title":"Nature."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1586\/erv.11.113","article-title":"Expert Review of Vaccines The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria.","author":"L Hviid","year":"2014"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"605367","DOI":"10.3389\/FCIMB.2020.605367\/TEXT","article-title":"Identification of a Novel RAMA\/RON3 Rhoptry Protein Complex in Plasmodium falciparum Merozoites.","volume":"10","author":"D Ito","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"1197126","DOI":"10.3389\/FCIMB.2023.1197126\/TEXT","article-title":"Roles of the RON3 C-terminal fragment in erythrocyte invasion and blood-stage parasite proliferation in Plasmodium falciparum.","volume":"13","author":"D Ito","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"138-146","DOI":"10.4269\/AJTMH.22-0773","article-title":"Safety and Immunogenicity of Radiation-Attenuated PfSPZ Vaccine in Equatoguinean Infants, Children, and Adults.","volume":"109","author":"S Jongo","year":"2023","journal-title":"The American Journal of Tropical Medicine and Hygiene."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e13332","DOI":"10.1111\/CMI.13332","article-title":"Characterisation of complexes formed by parasite proteins exported into the host cell compartment of Plasmodium falciparum infected red blood cells.","volume":"23","author":"T Jonsdottir","year":"2021","journal-title":"Cell. Microbiol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e0187817","DOI":"10.1371\/JOURNAL.PONE.0187817","article-title":"PFI1785w: A highly conserved protein associated with pregnancy associated malaria.","volume":"12","author":"C Kamaliddin","year":"2017","journal-title":"PLOS ONE."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"102224","DOI":"10.1016\/J.PARINT.2020.102224","article-title":"Leveraging the wheat germ cell-free protein synthesis system to accelerate malaria vaccine development.","volume":"80","author":"B Kanoi","year":"2021","journal-title":"Parasitol. Int."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"893","DOI":"10.3389\/fimmu.2020.00893","article-title":"Global Repertoire of Human Antibodies Against Plasmodium falciparum RIFINs, SURFINs, and STEVORs in a Malaria Exposed Population.","volume":"11","author":"B Kanoi","year":"2020","journal-title":"Front. Immunol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"2011-2022","DOI":"10.1093\/INFDIS\/JIAB550","article-title":"An Invariant Protein That Colocalizes With VAR2CSA on Plasmodium falciparum-Infected Red Cells Binds to Chondroitin Sulfate A.","volume":"225","author":"G Keitany","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1128\/MBIO.01460-19\/SUPPL_FILE\/MBIO.01460-19-SF005.TIF","article-title":"Deletion of Plasmodium falciparum protein RON3 affects the functional translocation of exported proteins and glucose uptake.","volume":"10","author":"L Low","year":"2019","journal-title":"MBio."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"380-391","DOI":"10.1038\/S41564-020-00858-9","article-title":"Structural basis for placental malaria mediated by Plasmodium falciparum VAR2CSA.","volume":"6","author":"R Ma","year":"2021","journal-title":"Nat. Microbiol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"e1011879","DOI":"10.1371\/JOURNAL.PPAT.1011879","article-title":"Structure-guided design of VAR2CSA-based immunogens and a cocktail strategy for a placental malaria vaccine.","volume":"20","author":"R Ma","year":"2024","journal-title":"PLoS Pathog."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"6930-6936","DOI":"10.1016\/j.vaccine.2019.09.057","article-title":"Safety and immunogenicity of the P. falciparum placental malaria vaccine PAMVAC in healthy adult women.","volume":"37","author":"B Mordm\u00fcller","year":"2019","journal-title":"Vaccine."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1509-1516","DOI":"10.1093\/cid\/ciy1140","article-title":"First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria.","volume":"69","author":"B Mordm\u00fcller","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-271","article-title":"Pregnancy-associated malaria and malaria in infants: An old problem with present consequences.","volume":"13","author":"V Moya-Alvarez","year":"2014","journal-title":"Malar. J."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"224","DOI":"10.12688\/OPENRESEUROPE.18351.1","article-title":"The pregnancy-associated secretome in malaria pathogenesis and immunity during gestation.","volume":"4","author":"L Mwai","year":"2024","journal-title":"Open Res Eur."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1622435","DOI":"10.3389\/FIMMU.2025.1622435","article-title":"Exploring the P. falciparum antigens associated with reduced risk of malaria in pregnancy.","volume":"16","author":"L Mwai","year":"2025","journal-title":"Front. Immunol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"199-214","DOI":"10.1080\/14760584.2021.1873135","article-title":"Structural vaccinology of malaria transmission-blocking vaccines.","volume":"20","author":"P Patel","year":"2021","journal-title":"Expert Rev. Vaccines."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"613-624","DOI":"10.1080\/14760584.2017.1322512","article-title":"Pre-clinical and clinical development of the first placental malaria vaccine.","volume":"16","author":"C Pehrson","year":"2017","journal-title":"Expert Rev. Vaccines."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e1010924","DOI":"10.1371\/JOURNAL.PPAT.1010924","article-title":"Cryo-EM reveals the conformational epitope of human monoclonal antibody PAM1.4 broadly reacting with polymorphic malarial protein VAR2CSA.","volume":"18","author":"S Raghavan","year":"2022","journal-title":"PLoS Pathog."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/S42003-021-02787-7","article-title":"Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity.","volume":"4","author":"J Renn","year":"2021","journal-title":"Commun Biol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"7","DOI":"10.12688\/OPENRESEUROPE.18580.1","article-title":"Targeting Plasmodium falciparum chondroitin sulfate a ligand: A highly conserved malaria antigen with potential for pregnancy-associated malaria vaccine development.","volume":"5","author":"A Rotich","year":"2025","journal-title":"Open Research Europe."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"988284","DOI":"10.3389\/FITD.2022.988284\/BIBTEX","article-title":"Towards identification and development of alternative vaccines against pregnancy-associated malaria based on naturally acquired immunity.","volume":"3","author":"A Rotich","year":"2022","journal-title":"Front Trop Dis."},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3389\/FMICB.2019.02712","article-title":"Plasmodium falciparum Blood Stage Antimalarial Vaccines: An Analysis of Ongoing Clinical Trials and New Perspectives Related to Synthetic Vaccines.","volume":"10","author":"D Salamanca","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"4259-4280","DOI":"10.1016\/J.JMB.2019.05.018","article-title":"Blood-Stage Malaria Parasite Antigens: Structure, Function, and Vaccine Potential.","volume":"431","author":"N Salinas","year":"2019","journal-title":"J. Mol. Biol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1052-1059","DOI":"10.1101\/GR.2126104","article-title":"A Plasmodium Gene Family Encoding Maurer\u2019s Cleft Membrane Proteins: Structural Properties and Expression Profiling.","volume":"14","author":"T Sam-Yellowe","year":"2004","journal-title":"Genome Res."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"1-22","DOI":"10.1186\/GB-2006-7-2-R12\/FIGURES\/7","article-title":"Lineage-specific expansion of proteins exported to erythrocytes in malaria parasites.","volume":"7","author":"T Sargeant","year":"2006","journal-title":"Genome Biol."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1359-1365","DOI":"10.1126\/SCIENCE.1241800","article-title":"Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine.","volume":"341","author":"R Seder","year":"2013","journal-title":"Science (New York, N.Y.)."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"585-597","DOI":"10.1016\/S1473-3099(19)30739-X","article-title":"PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study.","volume":"20","author":"S Sirima","year":"2020 May","journal-title":"Lancet Infect Dis."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1-10","DOI":"10.1038\/s41541-017-0015-7","article-title":"A malaria vaccine protects Aotus monkeys against virulent Plasmodium falciparum infection.","volume":"2","author":"P Srinivasan","year":"2017","journal-title":"Npj Vaccines."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"e20270","DOI":"10.1371\/JOURNAL.PONE.0020270","article-title":"Var2CSA Minimal CSA Binding Region Is Located within the N-Terminal Region.","volume":"6","author":"A Srivastava","year":"2011","journal-title":"PLOS ONE."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"e00019-e00019","DOI":"10.1128\/CMR.00019-19","article-title":"Plasmodium Genomics and Genetics: New Insights into Malaria Pathogenesis, Drug Resistance, Epidemiology, and Evolution.","volume":"32","author":"X Su","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"109-116","DOI":"10.1016\/J.MOLBIOPARA.2009.04.003","article-title":"The varieties of gene amplification, diversification and hypervariability in the human malaria parasite, Plasmodium falciparum.","volume":"166","author":"T Templeton","year":"2009","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"1004-1013","DOI":"10.1056\/NEJMOA1008115","article-title":"A field trial to assess a blood-stage malaria vaccine.","volume":"365","author":"M Thera","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"813-823","DOI":"10.3201\/EID2105.141626","article-title":"Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, Benin - Volume 21, Number 5\u2014May 2015 - Emerging Infectious Diseases journal - CDC.","volume":"21","author":"N Tuikue Ndam","year":"2015","journal-title":"Emerg. Infect. Dis."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1173-1182","DOI":"10.1517\/14712598.2015.1049595","article-title":"Developing vaccines to prevent malaria in pregnant women.","volume":"15","author":"N Tuikue-Ndam","year":"2015","journal-title":"Expert. Opin. Biol. Ther."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"e1004670","DOI":"10.1371\/JOURNAL.PPAT.1004670","article-title":"Revealing the Sequence and Resulting Cellular Morphology of Receptor-Ligand Interactions during Plasmodium falciparum Invasion of Erythrocytes.","volume":"11","author":"G Weiss","year":"2015","journal-title":"PLoS Pathog."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"401-414","DOI":"10.1046\/J.1440-1711.2002.01107.X","article-title":"Immunity to asexual blood stage malaria and vaccine approaches.","volume":"80","author":"J Wipasa","year":"2002","journal-title":"Immunol. Cell Biol."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"162-171","DOI":"10.1007\/S40475-020-00213-2\/METRICS","article-title":"Placental Malaria.","volume":"7","author":"A Zakama","year":"2020","journal-title":"Curr. Trop. Med. Rep."}],"container-title":["Open Research Africa"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/openresearchafrica.org\/articles\/9-18\/v1\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openresearchafrica.org\/articles\/9-18\/v1\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/openresearchafrica.org\/articles\/9-18\/v1\/iparadigms","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:04:49Z","timestamp":1791965089000},"score":1,"resource":{"primary":{"URL":"https:\/\/openresearchafrica.org\/articles\/9-18\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":59,"URL":"https:\/\/doi.org\/10.12688\/openresafrica.16523.1","relation":{"has-review":[{"id-type":"doi","id":"10.21956\/openresafrica.17711.r34946","asserted-by":"subject"},{"id-type":"doi","id":"10.21956\/openresafrica.17711.r34941","asserted-by":"subject"},{"id-type":"doi","id":"10.21956\/openresafrica.17711.r34517","asserted-by":"subject"},{"id-type":"doi","id":"10.21956\/openresafrica.17711.r34946","asserted-by":"object"},{"id-type":"doi","id":"10.21956\/openresafrica.17711.r34517","asserted-by":"object"},{"id-type":"doi","id":"10.21956\/openresafrica.17711.r34941","asserted-by":"object"}]},"ISSN":["2752-6925"],"issn-type":[{"value":"2752-6925","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"Indexed","URL":"https:\/\/openresearchafrica.org\/articles\/9-18\/v1#article-reports","order":0,"name":"referee-status","label":"Referee status","group":{"name":"current-referee-status","label":"Current Referee Status"}},{"value":"10.21956\/openresafrica.17711.r34517, Hideyuki Iriko, Kobe University, Kobe, Hy\u014dgo, 20 May 2026, version 1, indexed","URL":"https:\/\/openresearchafrica.org\/articles\/9-18\/v1#referee-response-34517","order":0,"name":"referee-response-34517","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.21956\/openresafrica.17711.r34946, Stephen Rogerson, The University of Melbourne, Parkville, VIC, 24 Jun 2026, version 1, indexed","URL":"https:\/\/openresearchafrica.org\/articles\/9-18\/v1#referee-response-34946","order":1,"name":"referee-response-34946","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"10.21956\/openresafrica.17711.r34941, Michael F. Ofori, Noguchi Memorial Institute for Medical Research, College of Health Sciences,University of Ghana, Accra, 03 Jul 2026, version 1, indexed","URL":"https:\/\/openresearchafrica.org\/articles\/9-18\/v1#referee-response-34941","order":2,"name":"referee-response-34941","label":"Referee Report","group":{"name":"article-reports","label":"Article Reports"}},{"value":"The author(s) declared that no grants were involved in supporting this work","order":3,"name":"grant-information","label":"Grant Information"},{"value":"This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.","order":0,"name":"copyright-info","label":"Copyright"}]}}